Own experience with axitinib in the treatment of metastatic renal cell carcinoma
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Šámal Vladimír | cs |
dc.contributor.author | Hejzlarová Věra | cs |
dc.contributor.author | Bartoš Jiří | cs |
dc.date.accessioned | 2020-06-08T09:38:51Z | |
dc.date.available | 20-32-2019 | en |
dc.date.available | 2020-06-08T09:38:51Z | |
dc.date.issued | 2018 | cs |
dc.date.updated | 29-03-2019 | en |
dc.format.extent | 4 | cs |
dc.identifier.issn | 1802-4475 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/155555 | |
dc.language.iso | cze | cs |
dc.publisher | Solen | cs |
dc.publisher.city | Olomouc | cs |
dc.relation.ispartof | Onkologie | en |
dc.relation.ispartofseries | 1 | cs |
dc.subject | renal carcinoma | cs |
dc.subject | targeted therapy | cs |
dc.subject | axitinib | cs |
dc.subject | treatment toxicity | cs |
dc.subject | overall survival and progression-free survival | cs |
dc.title | Own experience with axitinib in the treatment of metastatic renal cell carcinoma | en |
dc.title | Vlastní zkušenosti s axitinibem v léčbě metastatického karcinomu ledviny | cs |
local.citation.epage | 83-86 | cs |
local.citation.spage | 83-86 | cs |
local.identifier.publikace | 6159 | |
local.relation.issue | 2 | cs |